N'-(4-tert-butylphenyl)-N-cyano-4-[5-[(1S)-1,2-dihydroxyethyl]-3-fluoropyridin-2-yl]-4-fluoropiperidine-1-carboximidamide | 1073616-55-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: N'-(4-tert-butylphenyl)-N-cyano-4-[5-[(1S)-1,2-dihydroxyethyl]-3-fluoropyridin-2-yl]-4-fluoropiperidine-1-carboximidamide
• CAS: 1073616-55-3
• 化学式: C₂₄H₂₉F₂N₅O₂
• 分子量: 457.523
• InChiKey: XHGOGHXYLHCJOK-HXUWFJFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  33
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  105
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• TRPV1 antagonists and uses thereof
  申请人：Purdue Pharma L.P.

  公开号：EP2604598A1

  公开（公告）日：2013-06-19

  The invention relates to compounds of formula I and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula I or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula I or a pharmaceutically acceptable derivative thereof.

  本发明涉及式 I 的化合物 及其药学上可接受的衍生物，包含有效量的式 I 化合物或其药学上可接受的衍生物的组合物，以及治疗或预防疼痛、UI、溃疡、IBD 和肠易激综合征等病症的方法，包括向有需要的动物施用有效量的式 I 化合物或其药学上可接受的衍生物。
• TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF
  申请人：Tafesse Laykea

  公开号：US20090170868A1

  公开（公告）日：2009-07-02

  The invention relates to compounds of formula IA and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula IA or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula IA or a pharmaceutically acceptable derivative thereof.
• TRPV1 ANTAGONISTS INCLUDING SULFONAMIDE SUBSTITUENT AND USES THEREOF
  申请人：Kurose Noriyuki

  公开号：US20090170867A1

  公开（公告）日：2009-07-02

  The invention relates to compounds of formula IA′ and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula IA′ or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula IA′ or a pharmaceutically acceptable derivative thereof.
• TRPV1 ANTAGONISTS INCLUDING AMIDE SUBSTITUENT AND USES THEREOF
  申请人：Tafesse Laykea

  公开号：US20090176796A1

  公开（公告）日：2009-07-09

  The invention relates to compounds of formula IA″ and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula IA″ or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula IA″ or a pharmaceutically acceptable derivative thereof.
• US8476277B2
  申请人：——

  公开号：US8476277B2

  公开（公告）日：2013-07-02